Your browser doesn't support javascript.
loading
Characterization, crystallization and preliminary crystallographic analysis of human recombinant cyclooxygenase-2.
Di Marco, S; Priestle, J P; Grütter, M G; Wennogle, L P; Boyar, W.
Afiliación
  • Di Marco S; Core Drug Discovery Technologies, Basel, Switzerland. dimarco@fmi.ch
Acta Crystallogr D Biol Crystallogr ; 53(Pt 2): 224-6, 1997 Mar 01.
Article en En | MEDLINE | ID: mdl-15299964
Purified recombinant membrane apoprotein cyclooxygenase-2 (COX-2) has been reconstituted with heme and characterized. The holoprotein has been crystallized in complex with the selective inhibitor CGP 28238 [6-(2,4-difluorophenoxy)-5- methylsulfonylamino-l-indanone] by the sitting-drop method of vapor diffusion using polyethylene glycol 2000 monomethyl ether as precipitant, in the presence of the nonionic detergent beta-octylglucoside. The crystals are orthorhombic, belonging to the space group P2(1)2(1)2 with cell dimensions a = 209.56, b = 71.28 and c = 93.82 A, and diffract to 2.5 A resolution. The asymmetric unit contains two COX-2 monomers, as confirmed by the molecular replacement solution and in agreement with the dimeric structure of the detergent-solubilized protein found with dynamic light scattering and size-exclusion chromatography. Structural work is in progress.
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Acta Crystallogr D Biol Crystallogr Año: 1997 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Acta Crystallogr D Biol Crystallogr Año: 1997 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos